1470 nm Disposable Endovenous Laser Fiber

Verify a Thai partner's establishment, product and shipment documents before committing to a sterile-device launch.

A staged document checklist for a first commercial shipment: confirm the Vietnamese circulation number, route the CFS and authorization letters, and separate customs labelling from market-release duties.

P.U. (A) 10 names a diode laser at 800 nm. A 1470 nm or 980 nm endovenous source, and a passive fiber, are not in column 2. Section 27 and section 5 are separate duties.

When a supplier says an NMPA class adjustment changed the certificate on file, which document a buyer may still cite, and when a shipment has to stop.

Which Indian authorization a sterile single-use device actually needs, who can hold it, what the Second Schedule charges, and which foreign approvals skip a clinical investigation.

Work is $172.68 in both settings on CPT 36478; the $733.49 gap between the $980.32 office amount and the $246.83 facility physician amount is practice expense.

An operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Brazilian market under RDC 751/2022, RDC 848/2024, the 14 August 2026 Código Único transition, 4-year MDSAP CBPF validity, IN 290/2024 AREE reliance, and the 2026 SIUD UDI database.

What to accept or send back when a clinic asks to resterilize a labeled single-use 1470 nm fiber, offers a reusable-fiber IFU, or treats a silent GEX title as clearance.

NMPA published Notice 14 on 15 September 2026; its 200 graded items apply from 1 November 2026. Until then, CFDA 2015 No. 218 remains the on-site inspection file.

An incoming-inspection and regulatory-clock guide for international distributors, OEM/private-label buyers, and hospital procurement leads evaluating Chinese Class II sterile device shipments, Announcement 21 remaining-variety deadlines, the 103 third-batch catalogue, and Announcement 15 exemptions on 18 September 2026.

An incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital clinical-engineering leads, and OEM buyers evaluating Chinese 1470 nm endovenous laser fiber shipments, partner-supplied generators, IEC 60601-2-22 editions, Laser Notice 56, and GB 9706.222 on 17 September 2026.

An incoming audit guide for medical device distributors, OEMs, and private-label partners: why 21 CFR 820.30 is reserved under QMSR, how ISO 13485:2016 Clause 7.3 carries the legal duties, what CP 7382.850 inspects under Design and Development, how EN ISO 13485 and GB/T 42061-2022 overlay the file, the DHF-to-medical-device-file pivot, and an 8-point buyer acceptance protocol.

An operational factory-qualification and supplier-audit guide for international distributors, private-label/OEM buyers and hospital procurement teams evaluating Chinese sterile medical-device manufacturers under NMPA Announcement No. 107 of 2025, the 132-article Good Manufacturing Practice effective 1 November 2026, and the simultaneous repeal of CFDA Announcement No. 64 of 2014.

An operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Mexican market under Ley General de Salud Articles 262 and 376, RIS Article 83 risk classes, the 2010 FDA/Canada and 2012 Japan equivalence agreements, and the 18 July 2025 Option F abbreviated pathway.

An operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Japanese market under PMD Act Articles 23-2, 23-2-4, and 23-2-17, MHLW Ordinance 169, and official PMDA user-fee schedules.

A field-by-field file-review guide for medical device distributors, OEM buyers, and hospital procurement teams evaluating sterile single-use suppliers after 2 February 2026: why 21 CFR 820.70, 820.75, and 820.80 are reserved, what ISO 13485 Clause 7.5 and 21 CFR 820.45 mandate for production, process validation, and labeling inspection, and how FDA Compliance Program 7382.850 audits Production and Service Provision.

An operational regulatory guide for international medical device distributors, OEM buyers and manufacturers placing sterile single-use devices on the Republic of Korea market under the Medical Devices Act, Enforcement Rule Article 65 fees, and Act No. 21263 QMS conformity rules.

An incoming audit guide for medical device distributors, OEMs, and hospital procurement teams: why 21 CFR 820.100 and 820.198 are reserved under QMSR, how ISO 13485 Clauses 8.2.2, 8.3, 8.5.2, and 8.5.3 carry the legal duties, what 21 CFR 820.35 adds on top, what CP 7382.850 inspects under Measurement, Analysis, and Improvement, why an MDR report is not the complaint file, and a 7-point buyer acceptance protocol.

A definitive, decision-led guide for international manufacturers and Singapore distributors: navigating Singapore Health Sciences Authority (HSA) medical device registration, SMDR listings, Class A SHARE notifications, Registrant mandates, dealer licences, GN-15 R13 evaluation pathways, and 2026 fee cards.

A practical buyer's audit guide for medical device purchasing and outsourcing files: why 21 CFR 820.50 is reserved under QMSR, how ISO 13485 Clauses 4.1.5 and 7.4 carry the legal duties, what FDA Compliance Program 7382.850 inspects, why supplier-audit reports are no longer exempt, and a 7-point incoming acceptance checklist.

An operational decision guide for international medical-device distributors, private-label/OEM buyers, and overseas manufacturers: navigating Health Canada Medical Device Licences (MDL) under SOR/98-282 s 26, Medical Device Establishment Licences (MDEL) under GUI-0016 Table 1, the mandatory MDSAP quality filing condition, Schedule 1 risk classification, official 1 April 2026 fees including the private-label MDL, MDALL versus MDEL listing verification boundaries, and the SOR/2026-110 modernization coming-into-force timeline.

An operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating Australian Register of Therapeutic Goods (ARTG) inclusion under the Therapeutic Goods Act 1989, the Australian sponsor mandate, Manufacturer Evidence pre-approval, TGA risk classification (Classes I, IIa, IIb, III), Comparable Overseas Regulator (COR) pathways, July 2026 fee schedules, and the class-phased 1 July 2026 Unique Device Identification (AusUDID) rollout.

A practical buyer's audit guide for medical device risk management files: separating ISO 13485 QMSR process mandates from ISO 14971 conformity, verifying EN ISO 14971:2019+A11:2021 for EU MDR, navigating China's GB/T 42062-2022, and executing a 7-point incoming acceptance protocol.

An operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating the Kingdom of Saudi Arabia's MDMA requirements under Law M/54, the Technical File Assessment route, SFDA Classes A–D (MDS-G008), the May 2025 fee schedule, the 3 May 2026 bundling criteria (MDS-G028), Authorized Representative mandates, importer establishment licensing, and port-clearance verification.

Buyers say ‘the laser.’ Certificates name a fiber, a generator, or a vague system.

An operational decision guide for international distributors, OEM buyers, and non-UK manufacturers: navigating Great Britain's CE-recognition timelines (2028 vs 2030), UKCA requirements under UK MDR 2002, UK Responsible Person mandates, DORS registration and 2026 fees, Northern Ireland EUDAMED rules, and the in-force June 2025 post-market surveillance obligations.

A practical buyer's audit guide for medical device biological safety files: matching endpoints to contact category and duration, verifying test-article final form, navigating the ISO 10993-1:2025 transition across FDA, EU MDR and China NMPA, and spotting disqualifying file gaps.

A practical field-by-field verification guide for medical device export certificates: authenticating FDA CFGs via FECV, validating EU MDR Article 60 certificates, checking UK MHRA free-sale documents, navigating China's May 2026 export certificate reforms, and matching scope to your RFQ.

A practical field-by-field certificate reading guide, scope-to-SKU matching table, IAF CertSearch and accreditation-body verification workflow, 2026 Global ACI transition decoder, fake/mill certificate triage, and distribution agreement evidence schedule.

A practical five-check verification workflow, five-field matching grid, registration-versus-clearance decoder, exempt-device exception rules, and agreement evidence schedule for international medical-device distributors.

A practical five-check verification workflow, certificate-number decoder, public database guide, and distribution-agreement evidence schedule for international distributors qualifying Chinese medical-device suppliers.

An original FDA surveillance analysis of 186 laser fiber clearances, 68 recalls, and 114 MAUDE adverse-event reports (2023–2026) translated into vascular incoming-acceptance criteria and supplier-qualification tests.

Thermal (EVLA, RFA) and non-thermal (MOCA, cyanoacrylate closure) varicose-vein ablation platforms sit on different regulatory rungs. EVLA laser fibers (FDA GEX, Class II 510(k)) and RFA/MOCA catheters (GEI/KRA, Class II 510(k)) clear by substantial equivalence, while cyanoacrylate vein closure (VenaSeal, PJQ, Class III PMA) is a single-manufacturer PMA device with zero 510(k) predicates. Evaluate regulatory fit, supplier evidence packs, and consumable workflow economics alongside clinical closure data before committing portfolio or RFQ volume.

A B2B buyer guide and total-cost-of-ownership framework for clinical directors, distributors, and procurement teams evaluating 1470 nm endovenous laser ablation (EVLA) systems.

A practical regulatory checklist for legal manufacturers, OEM brand owners, and contract manufacturers executing design transfer and classifying post-market changes under FDA QMSR, ISO 13485, EU MDR, and NMPA.

A market-entry regulatory guide for medical device distributors and regulatory leads preparing US FDA 510(k), EU MDR Class IIb, and China NMPA registration evidence packs for single-use 1470 nm medical laser fibers.

A 1470 nm single-use endovenous laser fiber must be matched to the console on wavelength, connector standard (SMA905), core diameter, numerical aperture, tip geometry (radial 360° vs bare-tip), introducer French size, and regulator-cleared status (FDA GEX / 21 CFR 878.4810 Class II 510(k); NMPA Class II; EU MDR IIb). Verify console compatibility and clearance before committing volume.

An ISO 13485 certificate is the opening question—not the answer.

Passing ISO 11607 requires more than a cleanroom pouch—it demands a validated forming and sealing process under Part 2, Arrhenius accelerated-aging calculations under ASTM F1980 confirmed by real-time stability, transport simulation under ASTM D4169, and lot-release seal strength and integrity criteria.

Determining who holds the UDI-DI, which issuing agency to use, and when database submission becomes mandatory under 21 CFR 830, EU MDR Article 27, and NMPA UDI Rules.

How the standard of care moved from open vein stripping to minimally-invasive endovenous treatment — and why the recurring single-use consumable, not the laser console, is the strategic prize for device makers and distributors.